TabsDetailsBasic DetailsDate Posted: Friday, December 6, 2019Status: CompleteHealth Outcome(s): respiratory syncytial virus (RSV)respiratory syncytial virus-associated illnessDescription: FDA’s Sentinel System was used to characterize the epidemiology of respiratory syncytial virus-associated illness (RSV-AI) in U.S. children between 1 month and 5 years of age from January 2008 through June 2016. Greater than 80% of cases were managed as outpatients and >50% of hospitalized children, including those requiring intensive care, had no traditional risk factors besides young chronologic age. Read More Deliverables (1)Sentinel Final Report: Epidemiology of Pediatric Respiratory Syncytial Virus-Associated Illness in FDA’s Sentinel SystemAdditional InformationAdditional DetailsFDA Center: CDERTime Period: January 1, 2008 - June 30, 2016Study Type: Modular ProgramAssessment Type: Exploratory AnalysesPopulation / Cohort: Children 1 month to 5 years of ageData Sources: Sentinel Distributed Database (SDD)Related Links: Respiratory Syncytial Virus in a Pediatric PopulationCharacterization of Pediatric Medical Conditions: Respiratory Syncytial Virus (RSV) Associated Illness2019 ICPE Poster: Epidemiology of Pediatric Respiratory Syncytial Virus-Associated Illnesses in Young Children